Systems pharmacology-based optimization of Ma Xing Shi Gan components for the enhanced treatment of chick health issues caused by infectious bronchitis virus
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1585293 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Huixin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory of the Traditional Chinese Medicine Agricultural Biogenomics, Changsha Medical University, Changsha, China. Hauptthemen laut MEDLINE: Infectious bronchitis virus, Poultry Diseases, Coronavirus Infections, Antiviral Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Infectious bronchitis virus (IBV) imposes severe economic burdens on the poultry industry, and current treatments face challenges in efficacy and sustainability, necessitating the development of novel therapeutic strategies. To address this, this study employed the Traditional Chinese Medicine Inheritance Computing Platform (TCMICS) to collect clinical prescriptions for IBV treatment, based on which two optimized versions of the traditional Chinese medicine Maxing Shigan Decoction (MXSG), namely MXSG-mix1 and MXSG-mix2, were designed. In vitro cell culture and in vivo chicken model experiments were then carried out, including egg testing, clinical symptom observation, immune function analysis, and viral load quantification, to assess the antiviral activity of the optimized formulations.
Methods
To explore the underlying mechanisms, liquid chromatography-mass spectrometry (LC-MS) was combined with network pharmacology to identify 28 active compounds in MXSG-mix and 47 key genes involved in viral replication, inflammation, and apoptosis pathways. Furthermore, molecular docking and RT-qPCR were performed, which confirmed that MXSG-mix downregulated BCL2 expression and interacted with AKT1 and CASP3, thus inhibiting IBV-induced cell apoptosis. Results and discussion The results showed that both MXSG-mix1 and MXSG-mix2 exhibited superior anti-IBV activity compared to traditional MXSG, effectively reducing viral load and improving immune responses in vivo. In conclusion, integrating TCMICS, LC-MS, and network pharmacology offers a novel paradigm for developing veterinary TCM formulations. The optimized MXSG-mix shows potential as an effective, multi-target therapeutic against IBV, providing valuable insights for future anti-viral drug development in poultry medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory of the Traditional Chinese Medicine Agricultural Biogenomics, Changsha Medical University, Changsha, China.
- Animal Experiment Center of Sichuan Academy of Chinese Medicine Sciences, Chengdu, China.
- College of Animal Science and Technology, Guangxi University Key Laboratory of Animal Breeding, Disease Control and Prevention, Nanning, China.
- College of Veterinary Medicine, Hunan Agricultural University, Changsha, Hunan, China.
Zitieren
APA
Liu, H., He, Y., Wang, C., Wei, X., Chen, J., & Wang, K. (2025). Systems pharmacology-based optimization of Ma Xing Shi Gan components for the enhanced treatment of chick health issues caused by infectious bronchitis virus. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1585293
Vancouver
Liu H, He Y, Wang C, Wei X, Chen J, Wang K. Systems pharmacology-based optimization of Ma Xing Shi Gan components for the enhanced treatment of chick health issues caused by infectious bronchitis virus. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1585293
BibTeX
@article{Liu2025,
author = {Liu, Huixin and He, Yang and Wang, Chenchen and Wei, Xiaofang and Chen, Jiayi and Wang, Kaijun},
title = {Systems pharmacology-based optimization of Ma Xing Shi Gan components for the enhanced treatment of chick health issues caused by infectious bronchitis virus},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1585293}
}
EUVIMED